Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-22-020638

Director bought 25,000 shares at $18.99 ($474,680)

From the SEC's structured data for this filing

Trades in this filing

William Arsani · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-21 Purchase : show line 1 in the form +25,000 $18.99 $474,680 2,797,501 I
Open-market purchases · 25,000 sh · avg $18.99 · $474,680
Loading xslF345X03/doc4.xml…